Clinical Trials on Severe, Refractory Asthma in Finland

Total 299 results

TILT Biotherapeutics Ltd.
Merck Sharp & Dohme LLC

Recruiting

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditions

United States, Finland
Orion Corporation, Orion Pharma

Completed

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus

Asthma

Finland
HUS Skin and Allergy Hospital
Revenio Research; Mehiläinen

Unknown

Impedance Pneumography in Assessment of Asthma Control in Preschool Children (IPAAC)

Asthma in Children | Wheezing

Finland
Humanigen, Inc.

Completed

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids (KB003-04)

Moderate-to-Severe Asthma

France, United Kingdom, United States, Australia, Poland, Ukraine
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (EASYRELIEF)

Asthma

Finland
Cytos Biotechnology AG

Terminated

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

Moderate to Severe Allergic Asthma

United States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
Helsinki University Central Hospital
Ida Montini foundation, www.tb-foundation.org

Completed

Comparison of Biologicals in Treatment of Severe Asthma (BiSA)

Asthma

Finland
University of Turku
Juselius Foundation, Helsinki, Finland; Foundation for Paediatric Research,... and other collaborators

Unknown

Viral Inception of Asthma: Prospective Study From Infancy to School-age (VINKU2)

Asthma

Finland
Seinajoki Central Hospital

Completed

Seinäjoki Adult Asthma Study (SAAS)

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (Reco-Pilot)

Asthma

Finland
Kuopio University Hospital

Completed

Saline Challenge in Monitoring Asthma Control

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Phase I Pharmacokinetic Study (BF-BLOCK) (BF-BLOCK)

Asthma

Finland
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Moderate to Severe Persistent Asthma

United States, China, Hungary, Korea, Republic of, Poland
Helsinki University Central Hospital

Recruiting

Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab) (AirGOs-biol)

Chronic Rhinosinusitis With Nasal Polyps | Asthma, Aspirin-Induced

Finland
University of Oulu
GlaxoSmithKline; Oulu University Hospital; Foundation of the Finnish Anti-Tuberculosis... and other collaborators

Completed

Effects of Regular Exercise on Adult Asthma

Asthma

Finland
Kuopio University Hospital

Completed

Stepping Down of Asthma Medication in Controlled Asthma

Asthma

Finland
Tampere University Hospital

Recruiting

Small Airway Inflammation and Dysfunction in Different Asthma Phenotypes

Asthma

Finland
WellO2 Oy
Oy Medfiles

Unknown

Effects of Combined Respiratory Muscle Training and Steam Inhalation

Asthma | Airway Obstruction | COPD

Finland
Tampere University
Professor Lauri Lehtimäki; Professor Mika Mäkelä; Professor Sanna Toppila-Salmi; Professor Ilkka Junttila

Not yet recruiting

Allergy, Asthma, and Atopic Eczema in Finland (FinnATOPY)

Asthma | Allergy | Rhinitis, Allergic | Asthma in Children | Atopic Dermatitis | Allergen Immunotherapy

Finland
Novartis Pharmaceuticals
Genentech, Inc.

Completed

Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma

Moderate to Severe Allergic Asthma

United States, Puerto Rico
Thrombologic ApS
Rigshospitalet, Denmark; Anders Perner

Terminated

Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis

Pneumonia

Finland, Denmark
Helsinki University Central Hospital
University of Helsinki; Finnish Institute for Health and Welfare; Finnish Defense...

Completed

Probiotics and Infections in Conscripts in Military Service

Gastrointestinal Diseases | Respiratory Tract Infections | Asthma Exacerbations

Finland
Helsinki University Central Hospital
University of Helsinki

Recruiting

Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Cholera | Typhoid Fever | Vaccine-Preventable Diseases

Finland
University of Oulu
Oulu University Hospital

Completed

Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization

Chest Pain | Fever of Unknown Origin | Dyspnea | Respiratory Virus Infection

Finland
University of Oulu

Completed

Intravenous Magnesium in Wheezy Bronchitis

Wheezy Bronchitis

Finland
Rhode Island Hospital
State of Rhode Island Department of Health; Providence Public School District; Pawtucket School Department and other collaborators

Active, not recruiting

Rhode Island Asthma Integrated Response Program (RI-AIR)

Asthma in Children

United States
Oulu University Hospital

Recruiting

Assessment of Oral and Nasal Breathing With Sensors Analyzing Algorithm

Asthma | Allergic Rhinitis | Nasal Polyps | COPD

Finland
Kuopio University Hospital
Medical University of Vienna; Rigshospitalet, Denmark; University College, London and other collaborators

Active, not recruiting

Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris (ReGenHeart)

Coronary Artery Disease | Refractory Angina Pectoris | Gene Transfer

Denmark, Finland
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Yellow Fever

Germany, France, Finland, Singapore, Spain, Thailand
Columbia University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Sleep Quality in High School Students With Asthma - II

Sleep | Asthma | Asthma in Children

United States
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers (PIFECO)

Pulmonary Disease, Chronic Obstructive | Asthma

United Kingdom, Finland
Hill-Rom

Completed

HFCWO in Hospitalized Asthmatic Children

Asthma | Bronchial Asthma | Status Asthmaticus

United States
Columbia University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Sleep Quality in High School Students With Asthma

Sleep | Asthma | Asthma in Children

United States
Rhode Island Hospital

Recruiting

Assessment for Implementation Methods in Sepsis (AIMS)

Septic Shock | Sepsis Severe

United States
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA (VYF02)

Yellow Fever (Healthy Volunteers)

United States
Rhode Island Hospital
University of Puerto Rico

Not yet recruiting

The Puerto Rico Asthma Integrated Response Program ("PR-AIR") (PR-AIR)

Pediatric Asthma

United States, Puerto Rico
The Miriam Hospital

Recruiting

De-resuscitation Informed by Ultrasound for Patients With Sepsis (DRI-US)

Sepsis | Septic Shock | Sepsis, Severe | Volume Overload

United States
Helsinki University Central Hospital

Unknown

Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid Vaccines (Ty21a-ASC)

Healthy

Finland
Rhode Island Hospital

Completed

Restrictive Intravenous Fluids Trial in Sepsis (RIFTS)

Septic Shock | Severe Sepsis

United States
Natural Resources Institute Finland
Tampere University

Recruiting

Nationwide Research on the Rewilding of Kindergarten Yards (Vahvistu)

Allergy | Cognitive Change | Microbial Colonization | Asthma in Children | Atopic Dermatitis | Respiratory Infection | Nature, Human

Finland
Rhode Island Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Intervention for Depressed Latina Mothers of Children With Asthma (MAADRE)

Maternal Depression | Pediatric Asthma

United States, Puerto Rico
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF) (SALIF)

Chronic Obstructive Pulmonary Disease | Asthma

Finland, Estonia
Kuopio University Hospital

Completed

Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients

Sepsis

Finland

Clinical Trials on Severe, Refractory Asthma in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations